Re:Medicare Millionaires Emerge in Data on Doctor Payments
by riahi on Wednesday April 09, 2014 @12:30PM
(#7560356)
Yes, but you have to remember that these are Medicare data. The prevalence of 65+ patients getting Her2+ breast cancer AND getting treatment with Herceptin is probably lower than the number of 65+ patients getting ARMD and going on treatment with Lucentis.
Unfortunately, I don't have a good source. The above is merely my speculation.
The other thing to remember is that if it did include ASP reimbursement, ophthalmologists wouldn't be at the top, oncologists would. If a cancer doc saw 200 HER2 positive breast cancer patients in one year (16/month), treating them with Herceptin alone would cost $14,000,000. Most docs I've spoken to see 100-200 cancer patients per month (of course not all get treated with expensive drugs).